Temple University Health System’s preparations for and treatment of patients amidst the coronavirus pandemic continue to be part of the media’s COVID-19 coverage.
- 6ABC interviewed Nina Gentile, MD, Professor of Emergency Medicine and Research Director in the Department of Emergency Medicine at the Lewis Katz School of Medicine at Temple University, about results from the Janssen Pharmaceutical Companies of Johnson & Johnson’s Phase 3 clinical research study to evaluate the safety and efficacy of Janssen’s investigational COVID-19 vaccine candidate. Dr. Gentile is the principal investigator at Temple University Hospital, a testing site for the trial. The full interview was published on 6ABC’s streaming apps, including Fire TV, Roku, Apple TV and Android TV.
- Riyaz Bashir, MD, FACC, Professor of Medicine at the Lewis Katz School of Medicine at Temple University and Director of Vascular and Endovascular Medicine at Temple University Hospital, joined a Pennsylvania Department of Health press briefing to share his experience receiving the COVID-19 vaccine. The Philadelphia Inquirer featured some of Dr. Bashir’s comments in its online roundup of coronavirus-related news.
- Delana Wardlaw, MD, who practices at Temple Physicians, Inc. at Nicetown, spoke with CBS3 about the disparities in who is receiving the COVID-19 vaccine and how the digital divide contributes to that.
- Jason Gallagher, PharmD, FCCP, FIDP, FIDSA, BCPS, Clinical Professor and Director of the Postgraduate Year Two Infectious Diseases Residency at the Temple University School of Pharmacy and Clinical Pharmacy Specialist in Infectious Diseases at Temple University Hospital, spoke with the Verge about the certification process for pharmacists to administer COVID-19 vaccines and with Medscape about monoclonal antibodies as a treatment for COVID-19.